Inventor
Revati SHREENIWAS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61MDevices for introducing media into, or onto, the body20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
Y02ATechnologies for adaptation to climate change20%
PatentTitleYear
12,364,701PDE5 inhibitor powder formulations and methods relating thereto202512,263,174Methods and compositions for treatment of pulmonary hypertension and other lung disorders202511,911,390PDE5 inhibitor powder formulations and methods relating thereto202411,806,314PDE5 inhibitor powder formulations and methods relating thereto202311,491,160Methods and compositions for treatment of pulmonary hypertension and other lung disorders202211,491,161Methods and compositions for treatment of pulmonary hypertension and other lung disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to RESPIRA THERAPEUTICS INC (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RESPIRA THERAPEUTICS INC | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |